Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Icon
ICLR
$13.2B
| $71.2M | 0.11% |
550,844
-185,888
| -25% | -$25.7M |
|
227
Synchrony
SYF
$26B
| $71.1M | 0.11% |
3,032,475
+1,881,871
| +164% | +$50.9M |
|
228
CALL
Apple
AAPL
$4.57T
| $71M | 0.11% |
1,801,200
+1,442,800
| +403% | +$69.9M |
|
229
Petrobras
PBR
$120B
| $70.9M | 0.11% |
5,448,311
+166,896
| +3% | +$2.42M |
|
230
Newell Brands
NWL
$2.6B
| $70.3M | 0.11% |
3,781,478
+3,256,081
| +620% | +$64.8M |
|
231
Johnson & Johnson
JNJ
$660B
| $70.2M | 0.11% |
544,136
-995,099
| -65% | -$139M |
|
232
Elevance Health
ELV
$87.3B
| $70.1M | 0.11% |
267,032
-12,806
| -5% | -$3.52M |
|
233
Hilton Worldwide
HLT
$74.1B
| $69.9M | 0.11% |
973,263
-202,791
| -17% | -$14.7M |
|
234
Wendy's
WEN
$1.69B
| $69.7M | 0.11% |
4,464,560
-658,862
| -13% | -$11.2M |
|
235
Home Depot
HD
$335B
| $69.6M | 0.11% |
404,849
-256,828
| -39% | -$46.1M |
|
|
IPG
236
DELISTED
Interpublic Group of Companies
IPG
| $69.5M | 0.11% |
3,369,483
+2,327,356
| +223% | +$53.2M |
|
237
Marathon Petroleum
MPC
$101B
| $69.5M | 0.11% |
1,177,085
-3,094,492
| -72% | -$211M |
|
238
CALL
Range Resources
RRC
$9.58B
| $69.3M | 0.11% |
7,241,800
+841,100
| +13% | +$12.8M |
|
|
DATA
239
DELISTED
Tableau Software, Inc.
DATA
| $69.1M | 0.11% |
575,863
+444,229
| +337% | +$49.7M |
|
240
S&P Global
SPGI
$127B
| $68.7M | 0.11% |
404,062
+93,140
| +30% | +$16.7M |
|
241
RingCentral
RNG
$5.55B
| $68.1M | 0.11% |
826,156
-3,710
| -0.4% | -$292K |
|
242
McKesson
MCK
$101B
| $67.9M | 0.11% |
614,762
-336,545
| -35% | -$42M |
|
243
Nutrien
NTR
$35.3B
| $67.9M | 0.11% |
1,444,713
+113,665
| +9% | +$5.93M |
|
244
iRhythm Holdings
IRTC
$4.22B
| $67.9M | 0.11% |
977,269
+229,090
| +31% | +$17.4M |
|
|
XLNX
245
DELISTED
Xilinx Inc
XLNX
| $67.8M | 0.11% |
795,464
-227,298
| -22% | -$19M |
|
246
Sempra
SRE
$54.7B
| $67.6M | 0.11% |
1,250,312
+604,228
| +94% | +$34.4M |
|
247
Ulta Beauty
ULTA
$23B
| $67.5M | 0.11% |
275,767
+135,848
| +97% | +$37.5M |
|
248
AGCO
AGCO
$7.61B
| $67M | 0.1% |
1,204,363
+811,239
| +206% | +$45.8M |
|
249
Canadian Pacific Kansas City
CP
$82.6B
| $66.9M | 0.1% |
1,884,420
+1,587,220
| +534% | +$63.5M |
|
250
Cummins
CMI
$78.9B
| $66.9M | 0.1% |
500,439
+259,140
| +107% | +$36.6M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.